{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:43:53Z","timestamp":1788173033600,"version":"build-2803163510"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2001,1]]},"DOI":"10.1053\/ejpn.2000.0455","type":"journal-article","created":{"date-parts":[[2006,12,14]],"date-time":"2006-12-14T07:10:57Z","timestamp":1166080257000},"page":"163-166","source":"Crossref","is-referenced-by-count":18,"special_numbering":"S1","title":["New antidepressive and antipsychotic drugs in juvenile neuronal ceroid lipofuscinoses \u2014 a pilot study"],"prefix":"10.1053","volume":"5","author":[{"given":"Maria L.","family":"B\u00e4ckman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eeva T.","family":"Aronen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pirkko R.","family":"Santavuori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/ejpn.2000.0455_bib1","series-title":"The Neuronal Ceroid Lipofuscinoses (Batten disease)","first-page":"55","article-title":"CLN3, Juvenile NCL","author":"Hoffman","year":"1999"},{"key":"10.1053\/ejpn.2000.0455_bib2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00710255","article-title":"Psychological symptoms and sleep disturbances in neuronal ceroid-lipofuscinoses (NCL)","volume":"16","author":"Santavuori","year":"1993","journal-title":"J Inher Metab Dis"},{"key":"10.1053\/ejpn.2000.0455_bib3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/ajmg.1320420421","article-title":"Neurology of the neuronal ceroidlipofuscinoses: Late infantile and juvenile types","volume":"42","author":"Boustany","year":"1992","journal-title":"Am J Med Genet"},{"key":"10.1053\/ejpn.2000.0455_bib4","series-title":"Synopsis of Psychiatry","article-title":"Schizophrenia","author":"Kaplan","year":"1998"},{"issue":"Suppl 12","key":"10.1053\/ejpn.2000.0455_bib5","first-page":"46","article-title":"Treatment of special populations with the atypical antipsychotics","volume":"59","year":"1998","journal-title":"J Clin Psychiat"},{"key":"10.1053\/ejpn.2000.0455_bib6","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4088\/JCP.v59n1202","article-title":"Use of atypical neuroleptics in child and adolescent psychiatry","volume":"59","author":"Toren","year":"1998","journal-title":"J Clin Psychiat"},{"key":"10.1053\/ejpn.2000.0455_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0140-6736(98)07059-7","article-title":"Psychopharmacotherapy in children and adults with intellectual disability","volume":"354","author":"Santosh","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/ejpn.2000.0455_bib8","first-page":"93","article-title":"A brief review of atypical antipsychotics in individuals with developmental disability","volume":"4","author":"Connor","year":"1998","journal-title":"Mental Hlth Aspects Develop Disabil"},{"key":"10.1053\/ejpn.2000.0455_bib9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1600-0447.1979.tb00244.x","article-title":"A clinical study of 44 patients with juvenile amaurotic family idiocy","volume":"59","author":"S\u00f8rensen","year":"1979","journal-title":"Acta Psychiat Scand"},{"key":"10.1053\/ejpn.2000.0455_bib10","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/BF00710257","article-title":"Seizures, depression and dementia in teenagers with Batten disease","volume":"16","author":"Boustany","year":"1993","journal-title":"J Inher Metab Dis"},{"key":"10.1053\/ejpn.2000.0455_bib11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1600-0404.1985.tb03178.x","article-title":"Antioxidant treatment in Spielmeyer-Sj\u00f6gren's disease","volume":"71","author":"Santavuori","year":"1985","journal-title":"Acta Neurol Scand"},{"key":"10.1053\/ejpn.2000.0455_bib12","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0140-6736(99)00860-0","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/ejpn.2000.0455_bib13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJM199903113401003","article-title":"Low dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease","volume":"340","year":"1999","journal-title":"New Engl J Med"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379805800315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379805800315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T16:56:52Z","timestamp":1547139412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379805800315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":13,"alternative-id":["S1090379805800315"],"URL":"https:\/\/doi.org\/10.1053\/ejpn.2000.0455","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}